The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

Novo Nordisk announced its oral GLP-1 has been approved by the FDA to reduce risk for major adverse cardiovascular events in high-risk adults with type 2 diabetes.Approval of oral semaglutide ...

Epioxa is the first epithelium-on cross-linking procedure approved in the U.S. Glaukos plans for Epioxa to be commercially ...

Adults with type 1 diabetes using one of three GLP-1-based medications had significantly greater reductions in body weight ...

With regard to respiratory tuberculosis-related deaths from 1999 to 2020, common populations included older adults, males and ...

Seed oils, though often found in unhealthy foods, serve an important role in a healthy diet by functioning as a “key source” ...

The FDA has accepted Pharming Group’s supplemental new drug application for leniolisib in treating activated phosphoinositide ...

Many patients with advanced cancer who prefer treatment that prioritizes quality of life receive therapies focused on preserving it.A retrospective analysis showed nearly 40% of individuals with ...

Patients with lupus nephritis who received hydroxychloroquine demonstrated a significantly lower risk for glomerular ...

Across several clinical outcomes, including 28-day mortality, beta-blocker esmolol was more effective than standard care and ...

Drugs commonly used in cancer immunotherapy carry the risk for ocular adverse events, according to a speaker.In a ...

Social determinants of health affect whether a patient undergoes cross-linking or transplantation for keratoconus, according ...